RichardGrallaMD
Oncology • New Hyde Park, NYProfessor, Medicine, A Einstein Coll of Med of Yeshiva Univ
Are you Dr. Gralla?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 60 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Lakeville Rd
New Hyde Park, NY 11042Phone+1 516-734-8900Fax+1 516-734-8934- Is this information wrong?
Summary
- Dr. Richard Gralla, MD is an oncologist in New Hyde Park, New York. He is currently licensed to practice medicine in New York and Louisiana. He is affiliated with NYC Health + Hospitals / Jacobi and NYC Health + Hospitals / South Brooklyn Health.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1974 - 1977
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1972 - 1974
University of Virginia School of MedicineClass of 1972
Certifications & Licensure
NY State Medical License 1974 - 2025
LA State Medical License 1990 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsDo Patients Regret Having Received Systemic Treatment for Advanced Non-Small Cell Lung Cancer: A Prospective EvaluationPatricia J. Hollen, Richard J. Gralla, Ryan D. Gentzler, R. Hall, Bethany Coyne, Haiying Cheng, Balazs Halmos, Jane Gildersleeve, Claudia Calderon, Ivora Hinton, Geoff...> ;The Oncologist. 2021 Mar 1
- 5 citationsA randomized trial of the electronic Lung Cancer Symptom Scale for quality-of-life assessment in patients with advanced non-small-cell lung cancer.J C Kuo, Donna Graham, Alexandra Salvarrey, F Kassam, Lisa W. Le, Frances A. Shepherd, Ronald Burkes, Patricia J. Hollen, Richard J. Gralla, Natasha B. Leighl> ;Current Oncology. 2020 May 1
- Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial a...Lee Schwartzberg, Rudolph Navari, Rebecca Clark-Snow, Ekaterine Arkania, Irena Radyukova, Kamal Patel, Daniel Voisin, Giada Rizzi, Rita Wickham, Richard J Gralla, Matt...> ;The Oncologist. 2020 Mar 1
- Join now to see all
Authored Content
- Evaluation of Health-Related Quality of Life and Symptoms in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer Treated with Nivolumab or Docetaxel in CheckMate 057September 2018
Press Mentions
5 Key Takeaways from Mesothelioma Expert TeleconferenceApril 9th, 2018
FDA Approves Rolapitant for CINVSeptember 2nd, 2015
Hospital Affiliations
NYC Health + Hospitals / South Brooklyn HealthBrooklyn, New York
NYC Health + Hospitals / JacobiBronx, New York
